etoposide [clinicaltrials_resource:7cb6076e8355e089ce983cf1f80658d9]
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]clinicaltrials:NCT00002643Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia [clinicaltrials:NCT00002704]Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia [clinicaltrials:NCT00002912]Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003575]
intervention [clinicaltrials_vocabulary:intervention]
etoposide [clinicaltrials_resource:7cb6076e8355e089ce983cf1f80658d9]
Bio2RDF identifier
7cb6076e8355e089ce983cf1f80658d9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7cb6076e8355e089ce983cf1f80658d9
arm group [clinicaltrials_vocabulary:arm-group]
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:7cb6076e8355e089ce983cf1f80658d9
title
etoposide
@en
type
label
etoposide [clinicaltrials_resource:7cb6076e8355e089ce983cf1f80658d9]
@en